Wedbush analyst Nick Setyan maintains Darden Restaurants (NYSE:DRI) with a Neutral and lowers the price target from $140 to $122.
FDA Grants Jardiance Breakthrough Therapy Designation For heart Failure With Preserved Ejection Fraction
September 9, 8:02 AM
The U.S. Food and Drug Administration (FDA) granted Breakthrough Therapy designation for Jardiance® (empagliflozin) as an investigational treatment for adults with heart failure with preserved ejection fraction
February 24, 9:55 AM
Telos® Corporation (NASDAQ: TLS), a leading provider of cyber, cloud and enterprise security solutions for the world's most security-conscious organizations, announced today a $1.5 million,
July 1, 4:17 PM
Horace Mann Educators Corporation (NYSE:HMN) today announced it is raising guidance for its 2021 EPS by more than 15% to $3.50 to $3.70 from $3.00 to $3.20, with